About Genomics Medicine Ireland
Genomics Medicine Ireland is a company based in Dublin (Ireland) founded in 2015 was acquired by Genuity Science in November 2018.. Genomics Medicine Ireland has raised $40 million across 1 funding round from investors including Arch Venture Partners, Genuity Science and Polaris Partners. Genomics Medicine Ireland operates in a competitive market with competitors including GSK, Metabolon, Avidity Biosciences, Sutro Biopharma and Maze Therapeutics, among others.
- Headquarter Dublin, Ireland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$40 M (USD)
in 1 rounds
-
Latest Funding Round
$40 M (USD), Series A
Oct 26, 2016
-
Investors
Arch Venture Partners
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Genuity Science
(Nov 27, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Genomics Medicine Ireland
Genomics Medicine Ireland has successfully raised a total of $40M through 1 strategic funding round. The most recent funding activity was a Series A round of $40 million completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $40.0M
-
First Round
First Round
(26 Oct 2016)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2016 | Amount | Series A - Genomics Medicine Ireland | Valuation | Polaris Partners , Arch Venture Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Genomics Medicine Ireland
Genomics Medicine Ireland has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Arch Venture Partners, Genuity Science and Polaris Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused venture capital firm
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Genomics Medicine Ireland
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Genomics Medicine Ireland
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genomics Medicine Ireland Comparisons
Competitors of Genomics Medicine Ireland
Genomics Medicine Ireland operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Metabolon, Avidity Biosciences, Sutro Biopharma and Maze Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genomics Medicine Ireland
Frequently Asked Questions about Genomics Medicine Ireland
When was Genomics Medicine Ireland founded?
Genomics Medicine Ireland was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Genomics Medicine Ireland located?
Genomics Medicine Ireland is headquartered in Dublin, Ireland.
Is Genomics Medicine Ireland a funded company?
Genomics Medicine Ireland is a funded company, having raised a total of $40M across 1 funding round to date. The company's 1st funding round was a Series A of $40M, raised on Oct 26, 2016.
What does Genomics Medicine Ireland do?
Genomics Medicine Ireland was founded in 2015 in Dublin, Ireland, within the genomics sector. A disease-specific population genomics database is constructed to analyze genetic relationships with conditions including Multiple Sclerosis, Rheumatoid Arthritis, and Alzheimers Disease. Unknown genetic risk factors for major diseases are identified through this work. Operations involve partnerships with Irish and international research organizations, pharmaceutical firms, government bodies, and clinical providers.
Who are the top competitors of Genomics Medicine Ireland?
Genomics Medicine Ireland's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Who are Genomics Medicine Ireland's investors?
Genomics Medicine Ireland has 5 investors. Key investors include Arch Venture Partners, Genuity Science, Polaris Partners, Google Ventures, and Ireland Strategic Investment Fund.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.